Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAPT | P10636 | 6/20 | 0.37 |
| ▸ | ALDH1A1 | P00352 | 6/20 | 0.37 |
| ▸ | MEN1 | O00255 | 5/20 | 0.37 |
| ▸ | KMT2A | Q03164 | 5/20 | 0.37 |
| ▸ | HPGD | P15428 | 5/20 | 0.37 |
| ▸ | NTSR1 | P30989 | 1/20 | 0.37 |
| ▸ | PTGES | O14684 | 2/20 | 0.36 |
| ▸ | CYP1B1 | Q16678 | 2/20 | 0.35 |
| ▸ | CYP1A1 | P04798 | 1/20 | 0.35 |
| ▸ | KDM4E | B2RXH2 | 4/20 | 0.35 |
| ▸ | LMNA | P02545 | 2/20 | 0.34 |
| ▸ | GLA | P06280 | 1/20 | 0.34 |
| ▸ | PDPK1 | O15530 | 3/20 | 0.34 |
| ▸ | ATM | Q13315 | 1/20 | 0.33 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.33 |
| ▸ | NPC1 | O15118 | 1/20 | 0.33 |
| ▸ | RECQL | P46063 | 1/20 | 0.33 |
| ▸ | RAB9A | P51151 | 1/20 | 0.33 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.33 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL19428816 | 1.00 | MAPT (0.37) | MAPTALDH1A1MEN1KMT2AHPGD | |
| SCHEMBL19266949 | 0.98 | MAPT (0.39) | MAPTALDH1A1MEN1KMT2AHPGD | |
| SCHEMBL19428815 | 0.98 | MAPT (0.39) | MAPTALDH1A1MEN1KMT2AHPGD | |
| SCHEMBL19266370 | 0.97 | MAPT (0.38) | MAPTALDH1A1MEN1KMT2AHPGD | |
| SCHEMBL19266277 | 0.97 | MAPT (0.38) | MAPTALDH1A1MEN1KMT2AHPGD | |
| SCHEMBL19428814 | 0.94 | MAPT (0.40) | MAPTALDH1A1MEN1KMT2AHPGD | |
| SCHEMBL19266587 | 0.94 | MAPT (0.40) | MAPTALDH1A1MEN1KMT2AHPGD | |
| SCHEMBL19428835 | 0.94 | KDM4E (0.36) | MAPTALDH1A1PTGESCYP1B1CYP1A1 | |
| SCHEMBL19266312 | 0.93 | CYP1A1 (0.42) | MAPTALDH1A1MEN1KMT2AHPGD | |
| SCHEMBL19266314 | 0.93 | CYP1A1 (0.42) | MAPTALDH1A1MEN1KMT2AHPGD |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-10035765-B2 | Nitrogen-containing polycyclic compound and organic light emitting device using same | LG CHEM, LTD. (KR) | 2018-07-31 | — | — | US | disclosed |
| US-10035765-B2 | Nitrogen-containing polycyclic compound and organic light emitting device using same | LG CHEM, LTD. (KR) | 2018-07-31 | — | — | US | disclosed |
| US-20170283379-A1 | NITROGEN-CONTAINING POLYCYCLIC COMPOUND AND ORGANIC LIGHT EMITTING DEVICE USING SAME (AS AMENDED) | LG CHEM, LTD. (KR) | 2017-10-05 | — | — | US | disclosed |
| US-20170283379-A1 | NITROGEN-CONTAINING POLYCYCLIC COMPOUND AND ORGANIC LIGHT EMITTING DEVICE USING SAME (AS AMENDED) | LG CHEM, LTD. (KR) | 2017-10-05 | — | — | US | disclosed |
| EP-3208271-A2 | NITROGEN-CONTAINING POLYCYCLIC COMPOUND AND ORGANIC LIGHT EMITTING ELEMENT USING SAME | LG Chem, Ltd. (KR) | 2017-08-23 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20170283379-A1 | NITROGEN-CONTAINING POLYCYCLIC COMPOUND AND ORGANIC LIGHT EMITTING DEVICE USING SAME (AS AMENDED) | PER2, CRY1, CRY2 | MAPT 1603/4885ALDH1A1 1815/4885MEN1 309/4885 |
| US-10035765-B2 | Nitrogen-containing polycyclic compound and organic light emitting device using same | NPM1, PER2, CRY1 | MAPT 1120/4885ALDH1A1 2342/4885MEN1 228/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.